Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Type I interferon signature in Sjögren's syndrome: pathophysiological and clinical implications.

Marketos N, Cinoku I, Rapti A, Mavragani CP.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):185-191. Epub 2019 Jul 11. Review.

2.

Subjective and Objective Outcomes in Patients With COPD After Pulmonary Rehabilitation - The Impact of Comorbidities.

Charikiopoulou M, Nikolaidis PT, Knechtle B, Rosemann T, Rapti A, Trakada G.

Front Physiol. 2019 Mar 22;10:286. doi: 10.3389/fphys.2019.00286. eCollection 2019.

3.
4.

Production of Added-Value Chemical Compounds through Bioconversions of Olive-Mill Wastewaters Blended with Crude Glycerol by a Yarrowia lipolytica Strain.

Sarris D, Rapti A, Papafotis N, Koutinas AA, Papanikolaou S.

Molecules. 2019 Jan 9;24(2). pii: E222. doi: 10.3390/molecules24020222.

5.

Esophagus lyomyoma diagnosed with convex endobronchial ultrasound (EBUS).

Zarogoulidis P, Laskou S, Katsaounis A, Pavlidis E, Giannakidis D, Koulouris C, Mantalovas S, Kougioumtzi I, Katsikogiannis N, Konstantinou F, Hohenforst-Schmidt W, Huang H, Bai C, Euthimiou A, Hatzibougas D, Fitili I, Sardeli C, Rapti A, Kesisoglou I, Sapalidis K.

Respir Med Case Rep. 2018 May 4;24:95-97. doi: 10.1016/j.rmcr.2018.05.005. eCollection 2018.

6.

Global longitudinal strain and long-term outcomes in asymptomatic extracardiac sarcoid patients with no apparent cardiovascular disease.

Felekos I, Aggeli C, Gialafos E, Kouranos V, Rapti A, Sfikakis P, Koulouris N, Tousoulis D.

Echocardiography. 2018 Jun;35(6):804-808. doi: 10.1111/echo.13846. Epub 2018 Feb 28.

PMID:
29490113
7.

Immunotherapy "Shock" with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma.

Zarogoulidis P, Huang H, Tsiouda T, Sardeli C, Trakada G, Veletza L, Kallianos A, Kosmidis C, Rapti A, Papaemmanouil L, Hatzibougias D, Drougas D, Bai C, Hohenforst-Schmidt W.

Respir Med Case Rep. 2017 Oct 26;22:283-286. doi: 10.1016/j.rmcr.2017.10.006. eCollection 2017.

8.

PerSubs: A Graph-Based Algorithm for the Identification of Perturbed Subpathways Caused by Complex Diseases.

Vrahatis AG, Rapti A, Sioutas S, Tsakalidis A.

Adv Exp Med Biol. 2017;988:215-224. doi: 10.1007/978-3-319-56246-9_17.

PMID:
28971401
9.

Immunotherapy "Shock" a case series of PD-L1 100% and pembrolizumab first-line treatment.

Zarogoulidis P, Athanasiou E, Tsiouda T, Hatzibougias D, Huang H, Bai C, Trakada G, Veletza L, Kallianos A, Kosmidis C, Barbetakis N, Paliouras D, Rapti A, Drougas D, Hohenforst-Schmidt W.

Respir Med Case Rep. 2017 Aug 29;22:197-202. doi: 10.1016/j.rmcr.2017.08.017. eCollection 2017.

10.

Nab-paclitaxel as First Line Treatment for NSCLC in Elderly Patients More Than 75 Years Old.

Zarogoulidis P, Huang H, Bai C, Petridis D, Papadopoulou S, Faniadou E, Eleftheriadou E, Trakada G, Cristoforos K, Rapti A, Yarmus L, Kopman DF, Man YG, Hohenforst-Schmidt W.

J Cancer. 2017 Jun 4;8(9):1673-1678. doi: 10.7150/jca.19463. eCollection 2017.

11.

"Liquid elbows" due to afatinib administration.

Zarogoulidis P, Chinelis P, Athanasiadou A, Porpodis K, Kallianos A, Rapti A, Trakada G, Velentza L, Huang H, Tsiouda T, Hohenforst-Schmidt W.

Respir Med Case Rep. 2017 Jun 23;22:64-66. doi: 10.1016/j.rmcr.2017.06.013. eCollection 2017.

12.

Re-biopsy after relapse of targeted therapy. T790M after epidermal growth factor mutation, where and why based on a case series.

Zarogoulidis P, Rapti A, Sardeli C, Chinelis P, Athanasiadou A, Paraskevaidou K, Kallianos A, Veletza L, Trakada G, Hohenforst-Schmidt W, Huang H.

Respir Med Case Rep. 2017 May 30;21:171-175. doi: 10.1016/j.rmcr.2017.05.013. eCollection 2017.

13.

Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis.

Kouranos V, Tzelepis GE, Rapti A, Mavrogeni S, Aggeli K, Douskou M, Prasad S, Koulouris N, Sfikakis P, Wells A, Gialafos E.

JACC Cardiovasc Imaging. 2017 Dec;10(12):1437-1447. doi: 10.1016/j.jcmg.2016.11.019. Epub 2017 Mar 15.

14.

Tissue is the issue and tissue competition. Re-biopsy for mutation T790: where and why?

Zarogoulidis P, Gaga M, Huang H, Darwiche K, Rapti A, Hohenforst-Schmidt W.

Clin Transl Med. 2017 Dec;6(1):6. doi: 10.1186/s40169-017-0135-8. Epub 2017 Jan 18.

15.

A patient with situs inversus totalis and lung cancer-a rare combination.

Grapatsas K, Piyis A, Neofotistos K, Tsilogianni Z, Zarogoulidis P, Paliouras D, Gogakos A, Barbetakis N, Organtzis J, Kioumis I, Porpodis K, Hohenforst-Schmidt W, Karapantzos I, Karapantzou C, Tsakiridis K, Rapti A, Charalampidis C, Kaselouris K.

Ann Transl Med. 2016 Nov;4(22):450. doi: 10.21037/atm.2016.11.30.

16.

During economic crisis can sleep questionnaires improve the value of oximetry for assessing sleep apnea?

Pataka A, Zarogoulidis P, Hohenforst-Schmidt W, Tsiouda T, Tsavlis D, Kioumis I, Papakala E, Karapantzos I, Karapantzou C, Rapti A, Tsakiridis K, Zarogoulidis K, Argyropoulou P.

Ann Transl Med. 2016 Nov;4(22):443. doi: 10.21037/atm.2016.11.06.

17.

Clinicopathological features and relation between anaplastic lymphoma kinase (ALK) mutation and histological subtype of lung adenocarcinoma in Eastern European Caucasian population.

Zaric B, Stojsic V, Panjkovic M, Tegeltija D, Stepanov V, Kovacevic T, Sarcev T, Radosavljevic D, Milovancev A, Adamidis V, Zarogoulidis P, Hohenforst-Schmidt W, Trakada G, Rapti A, Perin B.

J Cancer. 2016 Oct 25;7(15):2207-2212. eCollection 2016.

18.

Massive parallel sequencing and digital gene expression analysis reveals potential mechanisms to overcome therapy resistance in pulmonary neuroendocrine tumors.

Walter RF, Vollbrecht C, Christoph D, Werner R, Schmeller J, Flom E, Trakada G, Rapti A, Adamidis V, Hohenforst-Schmidt W, Kollmeier J, Mairinger T, Wohlschlaeger J, Zarogoulidis P, Porpodis K, Schmidt KW, Mairinger FD.

J Cancer. 2016 Oct 25;7(15):2165-2172. eCollection 2016.

19.

The role of small bowel capsule endoscopy and ileocolonoscopy in patients with nonspecific but suggestive symptoms of Crohn's disease.

Mitselos IV, Christodoulou DK, Katsanos KH, Tatsioni A, Rapti A, Eliakim R, Tsianos EV.

Eur J Gastroenterol Hepatol. 2016 Aug;28(8):882-9. doi: 10.1097/MEG.0000000000000644.

PMID:
27183502
20.

Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer and Eye Metastasis: Disease Relapse or a New Entity?

Zarogoulidis P, Lampaki S, Chinelis P, Lazaridis G, Baka S, Rapti A.

Med Hypothesis Discov Innov Ophthalmol. 2016 Winter;5(4):132-135.

21.

Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients.

Papadopoulou E, Tsoulos N, Tsirigoti A, Apessos A, Agiannitopoulos K, Metaxa-Mariatou V, Zarogoulidis K, Zarogoulidis P, Kasarakis D, Kakolyris S, Dahabreh J, Vlastos F, Zoublios C, Rapti A, Papageorgiou NG, Veldekis D, Gaga M, Aravantinos G, Karavasilis V, Karagiannidis N, Nasioulas G.

Oncol Lett. 2015 Oct;10(4):2176-2184. Epub 2015 Aug 12.

22.

Reduction of exercise capacity in sarcoidosis in relation to disease severity.

Kallianos A, Zarogoulidis P, Ampatzoglou F, Trakada G, Gialafos E, Pitsiou G, Pataka A, Veletza L, Zarogoulidis K, Hohenforst-Schmidt W, Petridis D, Kioumis I, Rapti A.

Patient Prefer Adherence. 2015 Aug 18;9:1179-88. doi: 10.2147/PPA.S86465. eCollection 2015.

23.

Impact of Dose Reductions, Delays Between Chemotherapy Cycles, and/or Shorter Courses of Adjuvant Chemotherapy in Stage II and III Colorectal Cancer Patients: a Single-Center Retrospective Study.

Sgouros J, Aravantinos G, Kouvatseas G, Rapti A, Stamoulis G, Bisvikis A, Res H, Samantas E.

J Gastrointest Cancer. 2015 Dec;46(4):343-9. doi: 10.1007/s12029-015-9746-8.

PMID:
26143067
24.

Vascular function and ocular involvement in sarcoidosis.

Siasos G, Paraskevopoulos T, Gialafos E, Rapti A, Oikonomou E, Zaromitidou M, Mourouzis K, Siasou G, Gouliopoulos N, Tsalamandris S, Vlasis K, Stefanadis C, Papavassiliou AG, Tousoulis D.

Microvasc Res. 2015 Jul;100:54-8. doi: 10.1016/j.mvr.2015.03.008. Epub 2015 Apr 29.

PMID:
25937082
25.

Prophylactic antibiotic administration for post cardiothoracic surgery sternal wounds: a retrospective study.

Pitsiou G, Kioumis I, Zarogoulidis K, Lazaridis G, Papaiwannou A, Tsirgogianni K, Karavergou A, Lampaki S, Rapti A, Trakada G, Zissimopoulos A, Karaiskos T, Madesis A, Drosos G, Zarogoulidis P.

Ann Transl Med. 2015 Mar;3(4):56. doi: 10.3978/j.issn.2305-5839.2015.03.22.

26.

Minimally invasive procedures.

Baltayiannis N, Michail C, Lazaridis G, Anagnostopoulos D, Baka S, Mpoukovinas I, Karavasilis V, Lampaki S, Papaiwannou A, Karavergou A, Kioumis I, Pitsiou G, Katsikogiannis N, Tsakiridis K, Rapti A, Trakada G, Zissimopoulos A, Zarogoulidis K, Zarogoulidis P.

Ann Transl Med. 2015 Mar;3(4):55. doi: 10.3978/j.issn.2305-5839.2015.03.24. Review.

27.

Heimlich valve and pneumothorax.

Gogakos A, Barbetakis N, Lazaridis G, Papaiwannou A, Karavergou A, Lampaki S, Baka S, Mpoukovinas I, Karavasilis V, Kioumis I, Pitsiou G, Katsikogiannis N, Tsakiridis K, Rapti A, Trakada G, Zissimopoulos A, Tsirgogianni K, Zarogoulidis K, Zarogoulidis P.

Ann Transl Med. 2015 Mar;3(4):54. doi: 10.3978/j.issn.2305-5839.2015.03.25. Review.

28.

Pneumothorax: an up to date "introduction".

Papagiannis A, Lazaridis G, Zarogoulidis K, Papaiwannou A, Karavergou A, Lampaki S, Baka S, Mpoukovinas I, Karavasilis V, Kioumis I, Pitsiou G, Katsikogiannis N, Tsakiridis K, Rapti A, Trakada G, Karapantzos I, Karapantzou C, Zissimopoulos A, Zarogoulidis P.

Ann Transl Med. 2015 Mar;3(4):53. doi: 10.3978/j.issn.2305-5839.2015.03.23. Review.

29.

Chest drainage systems in use.

Zisis C, Tsirgogianni K, Lazaridis G, Lampaki S, Baka S, Mpoukovinas I, Karavasilis V, Kioumis I, Pitsiou G, Katsikogiannis N, Tsakiridis K, Rapti A, Trakada G, Karapantzos I, Karapantzou C, Zissimopoulos A, Zarogoulidis K, Zarogoulidis P.

Ann Transl Med. 2015 Mar;3(3):43. doi: 10.3978/j.issn.2305-5839.2015.02.09.

30.

Pacemaker insertion.

Kotsakou M, Kioumis I, Lazaridis G, Pitsiou G, Lampaki S, Papaiwannou A, Karavergou A, Tsakiridis K, Katsikogiannis N, Karapantzos I, Karapantzou C, Baka S, Mpoukovinas I, Karavasilis V, Rapti A, Trakada G, Zissimopoulos A, Zarogoulidis K, Zarogoulidis P.

Ann Transl Med. 2015 Mar;3(3):42. doi: 10.3978/j.issn.2305-5839.2015.02.06.

31.

Pneumothorax from diagnosis to treatment, hands on course: Part II.

Zarogoulidis K, Papaiwannou A, Lazaridis G, Karavergou A, Lampaki S, Baka S, Mpoukovinas I, Karavasilis V, Kioumis I, Pitsiou G, Katsikogiannis N, Tsakiridis K, Rapti A, Trakada G, Karapantzos I, Karapantzou C, Zissimopoulos A, Zarogoulidis P.

Ann Transl Med. 2015 Mar;3(3):41. doi: 10.3978/j.issn.2305-5839.2015.02.10.

32.

Pneumothorax as a complication of central venous catheter insertion.

Tsotsolis N, Tsirgogianni K, Kioumis I, Pitsiou G, Baka S, Papaiwannou A, Karavergou A, Rapti A, Trakada G, Katsikogiannis N, Tsakiridis K, Karapantzos I, Karapantzou C, Barbetakis N, Zissimopoulos A, Kuhajda I, Andjelkovic D, Zarogoulidis K, Zarogoulidis P.

Ann Transl Med. 2015 Mar;3(3):40. doi: 10.3978/j.issn.2305-5839.2015.02.11.

33.

Lung cancer and eye metastases.

Lampaki S, Kioumis I, Pitsiou G, Lazaridis G, Syrigos K, Trakada G, Kakolyris S, Zarogoulidis K, Mpoukovinas I, Rapti A, Zarogoulidis P.

Med Hypothesis Discov Innov Ophthalmol. 2014 Summer;3(2):40-4. Review.

34.

BTNL2 gene SNPs as a contributing factor to sarcoidosis pathogenesis in a cohort of Greek patients.

Delaveri A, Rapti A, Poulou M, Fylaktou E, Tsipi M, Roussos C, Makrythanasis P, Kanavakis E, Tzetis M.

Meta Gene. 2014 Aug 31;2:619-30. doi: 10.1016/j.mgene.2014.07.009. eCollection 2014 Dec.

35.

Relationship between tumor necrosis factor-α (TNFA) gene polymorphisms and cardiac sarcoidosis.

Gialafos E, Triposkiadis F, Kouranos V, Rapti A, Kosmas I, Manali E, Giamouzis G, Elezoglou A, Peros I, Anagnostopoulou O, Koulouris N, Gazouli M.

In Vivo. 2014 Nov-Dec;28(6):1125-9.

PMID:
25398810
36.

Cardiopulmonary exercise testing (CPET) as preoperative test before lung resection.

Kallianos A, Rapti A, Tsimpoukis S, Charpidou A, Dannos I, Kainis E, Syrigos K.

In Vivo. 2014 Nov-Dec;28(6):1013-20. Review.

PMID:
25398794
37.

A gene therapy induced emphysema model and the protective role of stem cells.

Zarogoulidis P, Hohenforst-Schmidt W, Huang H, Sahpatzidou D, Freitag L, Sakkas L, Rapti A, Kioumis I, Pitsiou G, Kouzi-Koliakos K, Papamichail A, Papaiwannou A, Tsiouda T, Tsakiridis K, Porpodis K, Lampaki S, Organtzis J, Gschwendtner A, Zarogoulidis K.

Diagn Pathol. 2014 Nov 14;9:195. doi: 10.1186/s13000-014-0195-7.

38.

Experimentation with aerosol bonsetan, pirfenidone, treprostinil and sidenafil.

Huang H, Zarogoulidis P, Lampaki S, Organtzis J, Petridis D, Porpodis K, Papaiwannou A, Karageorgiou V, Pitsiou G, Kioumis I, Hohenforst-Schmidt W, Li Q, Darwiche K, Freitag L, Rapti A, Zarogoulidis K.

J Thorac Dis. 2014 Oct;6(10):1411-9. doi: 10.3978/j.issn.2072-1439.2014.08.38.

39.

Pneumothorax: from definition to diagnosis and treatment.

Zarogoulidis P, Kioumis I, Pitsiou G, Porpodis K, Lampaki S, Papaiwannou A, Katsikogiannis N, Zaric B, Branislav P, Secen N, Dryllis G, Machairiotis N, Rapti A, Zarogoulidis K.

J Thorac Dis. 2014 Oct;6(Suppl 4):S372-6. doi: 10.3978/j.issn.2072-1439.2014.09.24. Review.

40.

Enhancement of Aerosol Cisplatin Chemotherapy with Gene Therapy Expressing ABC10 protein in Respiratory System.

Hohenforst-Schmidt W, Zarogoulidis P, Linsmeier B, Kioumis I, Li Q, Huang H, Sachpatzidou D, Lampaki S, Organtzis J, Domvri K, Sakkas L, Zachariadis GA, Archontas KN, Kallianos A, Rapti A, Yarmus L, Zarogoulidis K, Brachmann J.

J Cancer. 2014 Mar 24;5(5):344-50. doi: 10.7150/jca.9021. eCollection 2014.

41.

Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach.

Petridis D, Zarogoulidis P, Kallianos A, Kioumis I, Trakada G, Spyratos D, Papaiwannou A, Porpodis K, Huang H, Rapti A, Hohenforst-Schmidt W, Zarogoulidis K.

Ther Clin Risk Manag. 2014 Feb 7;10:77-86. doi: 10.2147/TCRM.S57429. eCollection 2014.

42.

Myocardial stress perfusion-fibrosis imaging pattern in sarcoidosis, assessed by cardiovascular magnetic resonance imaging.

Mavrogeni S, Kouranos V, Sfikakis PP, Bratis K, Kitas GD, Manali E, Perros E, Vlasis K, Rapti A, Koulouris N, van Wijk K, Hautemann D, Reiber JH, Kolovou G, Tzelepis GE, Gialafos E.

Int J Cardiol. 2014 Mar 15;172(2):501-3. doi: 10.1016/j.ijcard.2014.01.006. Epub 2014 Jan 16. No abstract available.

PMID:
24476697
43.

Occupational exposure and lung cancer.

Spyratos D, Zarogoulidis P, Porpodis K, Tsakiridis K, Machairiotis N, Katsikogiannis N, Kougioumtzi I, Dryllis G, Kallianos A, Rapti A, Li C, Zarogoulidis K.

J Thorac Dis. 2013 Sep;5 Suppl 4:S440-5. doi: 10.3978/j.issn.2072-1439.2013.07.09. Review.

44.

Therapeutic procedure in small cell lung cancer.

Kallianos A, Rapti A, Zarogoulidis P, Tsakiridis K, Mpakas A, Katsikogiannis N, Kougioumtzi I, Li Q, Huang H, Zaric B, Perin B, Courcoutsakis N, Zarogoulidis K.

J Thorac Dis. 2013 Sep;5 Suppl 4:S420-4. doi: 10.3978/j.issn.2072-1439.2013.09.16. Review.

45.

Myocardial mechanics for the early detection of cardiac sarcoidosis.

Aggeli C, Felekos I, Tousoulis D, Gialafos E, Rapti A, Stefanadis C.

Int J Cardiol. 2013 Oct 12;168(5):4820-1. doi: 10.1016/j.ijcard.2013.07.010. Epub 2013 Jul 17. No abstract available.

PMID:
23870643
46.

Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today.

Kallianos A, Tsimpoukis S, Zarogoulidis P, Darwiche K, Charpidou A, Tsioulis I, Trakada G, Porpodis K, Spyratos D, Panoutsopoulos A, Veletza L, Kostopoulos K, Kostopoulos C, Karapantzos I, Tsakiridis K, Hohenforst-Schmidt W, Zarogoulidis K, Rapti A, Syrigos K.

Onco Targets Ther. 2013 May 31;6:609-13. doi: 10.2147/OTT.S44087. Print 2013.

47.

Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: a Hellenic Oncology Research Group (HORG) randomized phase 3 study.

Karampeazis A, Voutsina A, Souglakos J, Kentepozidis N, Giassas S, Christofillakis C, Kotsakis A, Papakotoulas P, Rapti A, Agelidou M, Agelaki S, Vamvakas L, Samonis G, Mavroudis D, Georgoulias V.

Cancer. 2013 Aug 1;119(15):2754-64. doi: 10.1002/cncr.28132. Epub 2013 May 9.

48.

Lymphangioleiomyomatosis: current and future.

Mavroudi M, Zarogoulidis P, Katsikogiannis N, Tsakiridis K, Huang H, Sakkas A, Kallianos A, Rapti A, Sarika E, Karapantzos I, Zarogoulidis K.

J Thorac Dis. 2013 Feb;5(1):74-9. doi: 10.3978/j.issn.2072-1439.2013.01.03.

49.

Elevated pulmonary arterial systolic pressure in patients with sarcoidosis: prevalence and risk factors.

Rapti A, Kouranos V, Gialafos E, Aggeli K, Moyssakis J, Kallianos A, Kostopoulos C, Anagnostopoulou O, Sfikakis PP, Wells AU, Tzelepis GE.

Lung. 2013 Feb;191(1):61-7. doi: 10.1007/s00408-012-9442-4. Epub 2012 Dec 11.

PMID:
23229755
50.

Six minute walking test and carbon monoxide diffusing capacity for non-small cell lung cancer: easy performed tests in every day practice.

Zarogoulidis P, Kerenidi T, Huang H, Kontakiotis T, Tremma O, Porpodis K, Kalianos A, Rapti A, Foroulis C, Zissimopoulos A, Courcoutsakis N, Zarogoulidis K.

J Thorac Dis. 2012 Dec;4(6):569-76. doi: 10.3978/j.issn.2072-1439.2012.08.18.

Supplemental Content

Support Center